ArticleClinical transplantation2026
Cardiac Troponin I (cTnI) Dynamics After Lung Transplantation and Its Consequences for Early Postoperative Management.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyocardial injury with elevated cardiac troponin I (cTnI) is common after cardiac or even thoracic surgery and may indicate impaired prognosis. While cTnI has been monitored after lung transplantation routinely (LuTX), its relevance is to be elucidated. Therefore, this study focused on cTnI dynamics and its prognostic value after LuTX.
methodsThis retrospective study analyzed data from 151 adult patients who underwent a LuTX at a single German lung center between 2005 and 2022. It focused on cTnI levels and dynamics at four postoperative time points, their impact on LuTX outcomes, and possible risk factors for elevated cTnI.
resultsElevated cTnI above the upper limit of normal was a regular finding early after LuTX without independent prognostic value, peaking 5-8 h postoperative. However, a failure to subsequently decrease may indicate a higher risk of mortality. Patients' cTnI levels showed weak positive correlations with duration of mechanical ventilation and length of stay in the intensive care unit. DISCUSSION: Elevated cTnI levels after LuTX might impact patient outcomes. However, larger multi-center studies are needed to conclusively determine their impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.